Microsoft Defender Denial of Service Vulnerability (CVE-2026-45498)

Historical catalog analysis: CISA added this entry on May 20, 2026. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. Check current vendor guidance before acting.

What the vulnerability is

On May 20, 2026, CISA added CVE-2026-45498 to its Known Exploited Vulnerabilities catalog. This entry identifies an unspecified vulnerability in Microsoft Defender that could allow an attacker to trigger a denial of service (DoS) condition.

Exposure and applicability

This vulnerability is applicable to healthcare organizations, practices, and business associates utilizing Microsoft Defender as their primary endpoint protection tool. In a clinical environment, the primary risk associated with a DoS event in security software is the potential for “blind spots.” If the security agent is disabled or crashed via this vulnerability, the organization may lose real-time visibility into other malicious activities on the affected host, potentially delaying the detection of ransomware or unauthorized access to ePHI.

Remediation priorities

Based on our analysis, healthcare security leaders should prioritize the following actions to maintain operational resilience:

1. Apply Vendor Mitigations: The primary priority is to implement the mitigations provided by Microsoft. This reduces the likelihood that the vulnerability can be used to disable endpoint protection.
2. Review Cloud Service Guidance: For organizations utilizing Defender via cloud services, we recommend following the guidance outlined in BOD 22-01 to ensure configuration alignment with current security standards.
3. Evaluate Alternative Controls: In scenarios where mitigations are unavailable or cannot be applied due to legacy system constraints (such as certain medical device workstations), organizations should evaluate whether to discontinue use of the affected version or implement compensating controls to limit network exposure.

How to validate remediation

To verify that the risk has been reduced, security teams should perform the following:

• Version Audit: Confirm through centralized management consoles that all endpoints are running the versions specified in the vendor’s mitigation guidance.
• Service Health Monitoring: Ensure that endpoint protection heartbeat monitoring is active. A sudden drop in reporting from a cluster of machines could indicate a DoS event, though this validates detection rather than prevention.

Note: We do not recommend attempting to trigger the DoS condition on production systems or medical devices, as this could disrupt patient care and clinical operations.

Limits and open questions

There are several unknowns regarding CVE-2026-45498. The specific technical mechanism used to trigger the denial of service remains unspecified in the available data. Additionally, it is unknown if this vulnerability has been utilized as part of active ransomware campaigns targeting the healthcare sector. Because a version check alone does not guarantee immunity from all attack vectors, residual risk remains until vendor patches are fully deployed and verified across the entire environment.

Source and editorial note

CVE-2026-45498: Microsoft Defender Denial of Service Vulnerability · Source date: May 20, 2026 · Retrieved August 31, 2026.

Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.

Archive date: May 23, 2026. The displayed post date is assigned three days after the source date to organize this retrospective archive; it does not mean this site published the analysis then. First published by this site: September 08, 2026 at 03:32 UTC.

Request a healthcare security assessment